TGR-1202– A novel PI3K-delta inhibitor that differentially regulates T cells in CLL

Drug Category : Array
Conference Category : Array
Lead Author : Pinilla-Ibarz, et al.
Published Date : 15/05/2017
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/2017%20iWCLL%20TGR-1202%20Preclinical%20Moffitt%20.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top